This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB06891/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB06891/identifier/pubchem-compound/
n11http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB06891/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB06891/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
n4http://linked.opendata.cz/resource/drugbank/drug/DB06891/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB06891
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n11:DB06891 n12:DB06891
dcterms:title
5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE
adms:identifier
n4:9244285 n7:11069133 n9:99443362 n13:DB06891 n14:1CN
n5:IUPAC-Name
n6:271B5C03-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5C09-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5C08-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5C05-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5C06-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5C07-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5C01-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5C02-363D-11E5-9242-09173F13E4C5 n6:271B5BFF-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5C00-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5C0F-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5C10-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5C0A-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5C0B-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5C0D-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5C0C-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5C0E-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5C15-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5C17-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5C18-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5C14-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5C13-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5C16-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5C04-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5C11-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5C12-363D-11E5-9242-09173F13E4C5